Jersey’s Slayback Pharma names new chief commercial officer

Slayback Pharma LLC, a Princeton-based pharmaceutical company, has named a new chief commercial officer, it announced Tuesday.

Dave Picard, who has held sales leadership positions with companies such as AmerisourceBergen, Sandoz and Bristol-Myers Squibb, will now head Slayback’s commercial function and oversee the crafting and driving of commercial strategy and infrastructure.

“A founding principle at the core of Slayback is that talent is the best asset class,” CEO and President Ajay Singh said in a prepared statement. “Our team is our first and foremost asset. In our pursuit to build the best team in the industry, I am particularly delighted to welcome Dave Picard as our chief commercial officer.”